Febuxostat CAS 144060-53-7 Puritas >99.0% (HPLC) API Factory

Description:

Nomen chemicum: Febuxostat

CAS: 144060-53-7

Puritas: >99.0% (HPLC)

Aspectus: Alba ad Off-White Crystalline pulveris

API High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Ruifu Chemical Supple Febuxostat intermedia:
Febuxostat CAS 144060-53-7
Ethyl 2-Chloroacetoacetate CAS 609-15-4
4-Hydroxythiobenzamide CAS, 25984-63-8
Ethyl 2-(3-Cyano-4-Hydroxyphenyl) -4-Methyl-1,3-Thiazole-5-Carboxylate CAS 161798-02-3
Ethyl 2-(3-Cyano-4-Isobutoxyphenyl) -4-Methyl-5-Thiazolecarboxylate CAS 160844-75-7
Ethyl 2-(3-Formyl-4-Hydroxyphenyl) -4-Methylthiazole-5-Carboxylatus CAS 161798-01-2
Ethyl 2-(3-Formyl-4-Isobutoxyphenyl) -4-Methylthiazole-5-Carboxylatus CAS 161798-03-4
Ethyl 2-(4-Hydroxyphenyl) -4-Methylthiazole-5-Carboxylatus CAS 161797-99-5

Chemical Properties:

Nomen chemicum	Febuxostat
Synonyma	2-(3-Cyano-4-Isobutoxyphenyl) -4-Methylthiazole-5-Carboxylic Acidum
CAS Number	144060-53-7
Stock Status	In Stock, Productio Ascendite ad Tons
Formulae hypotheticae	C16H16N2O3S
M. Pondus	316.38
Liquescens punctum	207.0 ad 211.0℃
Density	1.31±0.1 g/cm3
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Alba ad Off-White Crystalline pulveris
Lepidium sativum	HPLC/IR
Puritas / Analysis Methodus	> 99.0% (HPLC in exaruit basis)
Damnum in Siccatio	<1.00% (sicco in 105℃ in aura electrica flante dryer usque ad constantem pondus)
Ignition residua	<0.10%
Substantiae cognatae
Maximum Impuritas	<0.30%
Totalis immunditias	<1.00%
Chlorides	<0.04%
Metalla gravis	<20ppm
Test Standard	Enterprise Standard
Consuetudinem	API

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore

commoda:

FAQ:

Applicatio:

Febuxostat (CAS: 144060-53-7), sub nominibus notis Ulorici et Adenurici inter alios venditis, medicamentum diuturnum ad podagram tractandum propter gradus acidi urici alti.Communiter commendatur solum hominibus qui allopurinolum capere non possunt.Cum initio incepit, medicamentum ut NSAIDs saepe commendatur ad flammas podagras prohibendas.Capitur per os.Febuxostat probata est in usu medicorum in Unione Europaea anno MMVIII et in Civitatibus Foederatis Americae Septentrionalis anno 2009. Febuxostat dicitur podagra et hyperuricemia chronica tractare.Febuxostat typice commendatur solum hominibus qui allopurinolum ferre non possunt.